Clinical Trial Search

Primary: Effects of SonoVue and Placebo on Pulmonary Hemodynamics: Systolic Pulmonary Artery Pressure (mmHg) - Mean Change From Baseline — 50.50; 50.50; 30.08; 30.08 mmHg

Primary: Evaluate the Number of Clinical Events (Pooled) Occurring Between 3-15 Months Following a Switch/Stabilization of the Antipsychotic Agents Among Patients Who Receive…

Primary: Number of Clinically Significant Exacerbations of Asthma Per Year — 2.40; 1.24; 1.46; 1.15 Exacerbations per year — p=<0.001

Primary: Response — 0 percentage of participants

Primary: Left T6 Normalized Root Mean Square (RMS) Value — 3.72 ratio

Primary: Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12) — 71.9; 85.4; 92.9 percentage of participants

Primary: % Change in VO2max (Fitness) — 0; 10; 1.5 percentage change of VO2max — p=<0.05

Primary: Proportion of Patients Who Have Recanalization — 36 participants

Primary: HF Muscle Force — 23.9; 30.9 Newtons (N)

Primary: Postoperative Complications — 52; 72 numbers of complications

Primary: Mean Self-report Weekly Craving Via Obsessive Compulsive Drinking Scale (OCDS) — 21.273; 20.700; 18.500; 21.458 units on a scale

Primary: Baseline Adjusted Percent Predicted Forced Expiratory Volume In 1 Second (FEV1) Area Under The Concentration Time Curve Up From Time Zero up to 6 Hours (AUC0-6) Over 3…

Primary: Blood Levels of Drug — 1.5 ng/ml

Primary: Mean Postoperative Spherical Aberration — 0.069; 0.016 µm

Primary: Number of Participants With Objective Response Plus Stable Disease Rate (CR + PR + SD) — 0; 0; 14; 17 participants